NMS Labs Launches Testing Solution To Detect Pyrrolidinophenones, A New Group Of Designer Drugs

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WILLOW GROVE, Pa.--(BUSINESS WIRE)--NMS Labs announces the launch of its newest test offering for the latest group of agents to have come to the fore in the rapidly changing Designer Drug arena in the US. The Pyrrolidinophenones or “Pyrros” are potent stimulants with psychoactive properties becoming popular with young people and drug users looking for a newer, different high. Chemically related to some of the better known “Bath Salts” drugs such as methylone (“Molly”) and mephedrone (“meow meow“), the compounds are so new that they are not yet on the radar of many forensic toxicology labs.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC